Skip to content

Investigation into the Effects of Shao Lansun's Modified Xuanxiong Chengqi Decoction, a Prescription from the Shao School of Traditional Chinese Medicine, on Inflammatory Mediators and Immune Mechanisms in Patients with Parkinson's Disease Constipation Characterized by the Pattern of Phlegm-Heat Moving Wind

Investigation into the Effects of Shao Lansun's Modified Xuanxiong Chengqi Decoction, a Prescription from the Shao School of Traditional Chinese Medicine, on Inflammatory Mediators and Immune Mechanisms in Patients with Parkinson's Disease Constipation Characterized by the Pattern of Phlegm-Heat Moving Wind

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087750
Enrollment
Unknown
Registered
2024-08-02
Start date
2024-03-02
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease Constipation

Interventions

Sponsors

Shaoxing Hospital of Traditional Chinese Medicine,Shaoxing TCM Hospital Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Western medicine diagnosis consistent with both Parkinson's Disease (PD) and constipation criteria; (2) Traditional Chinese medicine diagnosis compatible with the criteria for tremor syndrome and constipation associated with the pattern of phlegm-heat stirring wind; (3) Patient age between 35 and 80 years; (4) Hoehn-Yahr staging from 1 to 4; (5) No use of laxatives within 2 weeks prior to treatment initiation, and capable of completing scheduled treatments and assessments as planned; (6) Clear mental state and stable vital signs; (7) Patient has provided informed consent and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Secondary Parkinsonian syndromes or Parkinson-plus syndromes of various types; (2) Patients with severe primary diseases of the circulatory system, digestive system, hematopoietic system, or malignant tumors, or those suffering from schizophrenia, mental retardation, or other severe psychiatric disorders that impair normal communication and cooperation in assessments and follow-ups; (3) Constipation caused by organic intestinal lesions such as incomplete mechanical bowel obstruction, megacolon, or suspected bowel obstruction, or constipation that cannot be solely explained by PD due to unknown reasons; (4) Patients with atopic constitution, a history of allergies to multiple Chinese herbs or their components, posing high risk for inclusion; (5) Poor compliance, refusal to take Chinese herbal granules, or inability to cooperate for other reasons; (6) Patients who have participated in other clinical trials within the past three months.

Design outcomes

Primary

MeasureTime frame
Interleukin-6;Interleukin-8;Tumor Necrosis Factor Alpha;Cluster of Differentiation 3 positive;Cluster of Differentiation 4 positive;Cluster of Differentiation 8 positive;

Countries

China

Contacts

Public ContactCHEN KEWEI

Department of Neurology Shaoxing Hospital of Traditional Chinese Medicine,Shaoxing TCM Hospital Affiliated to Zhejiang Chinese Medical University,Shaoxing,Zhejiang,China.

chen13857526575@163.com+86 138 5752 6575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026